Alzheimer; News from the web:

Sex differences in dementia are only just being recognised – but the consequences could change the way we fight the disease.

Read all about it HERE

Alzheimer; News from the web:

Biogen posts that BAN2401 met on the ADCOMS secondary endpoint measure in its phase 2 study treating patients with Alzheimer’s.

BAN2401 showed evidence that it could reduce the progression of Alzheimer’s.

The positive update for BAN2401 was a huge surprise, because the failure rate for creating a treatment for Alzheimer’s is 99.6%.

BAN2401 still has to go through a phase 3 study in order to prove that it works in treating patients with Alzheimer’s.

Biogen is not only relying on BAN2401 for Alzheimer’s treatment, it also has another drug in late-stage development for the disease known as Aducanumab.

Read all about it HERE

Alzheimer; News from the web:

A new study suggests promoting conversion of glucose into brain energy could reduce risk or delay disease onset in risk gene carriers

Read all about it HERE

Alzheimer; News from the web:

Strains of a virus that most people acquire in childhood may play a role in the development of Alzheimer’s disease later in life.

Research published June 21, 2018, in the scientific journal Neuron revealed that levels of two types of human herpes virus (HHV-6A and HHV-7) were twice as high in the brains of patients who died with Alzheimer’s disease compared with those who did not have the disease.

Read all about it HERE

Alzheimer; News from the web:

Research into problems with mathematics in patients with Alzheimer’s

Dyscalculia is an early sign of AD. It should be included among the reliable clinical hallmarks for the diagnosis of Alzheimer’s Disease. Identification of dyscalculic symptoms in these patients requires composite assessment procedure.

Read all about it: HERE